Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus
Authors:
- 1 October 2014
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 63 (10) , 1328-1338
Abstract
Visceral leishmaniasis (VL) is a vector-borne parasitic disease targeting tissue macrophages. It is among the most neglected infectious diseases. As available therapeutics for treatment of this disease have many side effects, there is a need for safer alternatives. One of the immunopathological consequences of active visceral leishmaniasis is suppression of protective T-helper (Th)-1 cells and induction of disease-promoting Th-2 cells, and thus the treatment of VL relies on immunomodulation. In the current study, herbal drugs derived as whole-plant extracts ofAsparagus racemosusandWithania somniferawere used to treatLeishmania donovani-infected BALB/c mice. Keeping the scenario of immunosuppression during VL in mind, the potential of these drugs in the restoration of murine Th-1-type protective immune responses was evaluated. To investigate the propensity of these drugs to treat VL, liver parasite load, delayed-type hypersensitivity responses and parasite-specific immunoglobulin levels were studied. Various biochemical and haematological tests were also carried out. A positive-control group used the standard drug treatment of sodium stibogluconate. Treatment of infected mice withA. racemosusandW. somniferain combination at the higher dose of 200 mg (kg body weight)−1not only resulted in a successful reduction in parasite load but also generated protective Th1-type immune responses with normalization of biochemical and haematological parameters, suggesting their potential as potent anti-leishmanial agents.Keywords
This publication has 24 references indexed in Scilit:
- Ashwagandha (Withania somnifera) Reverses β-Amyloid1-42 Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)PLOS ONE, 2013
- Adenosine and Immune Imbalance in Visceral Leishmaniasis: The Possible Role of EctonucleotidasesJournal of Tropical Medicine, 2011
- Protective effects of Asparagusracemosus on oxidative damage in isoniazid-induced hepatotoxic ratsToxicology and Industrial Health, 2011
- Treatment of visceral leishmaniasisJournal of Global Infectious Diseases, 2010
- Induction of cellular and humoral responses by autoclaved and heat-killed antigen of Leishmania donovani in experimental visceral leishmaniasisParasitology International, 2009
- Drug Resistance in Visceral LeishmaniasisJournal of Biomedicine and Biotechnology, 2009
- Nephroprotective Effect ofWithania somnifera:A Dose-Dependent StudyRenal Failure, 2009
- A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c miceLife Sciences, 2007
- Glycolipids and other constituents from Desmodium gangeticum with antileishmanial and immunomodulatory activitiesBioorganic & Medicinal Chemistry Letters, 2005
- Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug‐treated BALB/c miceImmunology & Cell Biology, 1992